$GALE Recent News FutureFuel shares rally on big profit

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 1:45 PM

$GALE Recent News

FutureFuel shares rally on big profit jump 4:20 p.m. March 17, 2014 - Wallace Witkowski
3 best hedge fund managers of 2013 1:50 p.m. Jan. 22, 2014 - Insider Monkey
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck

First patient dosed in NeuVax Phase 2 breast cancer trial 12:04 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 4:40 p.m. Nov. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Monday’s close 5:35 p.m. Nov. 2, 2014 - Seeking Alpha
Galena gets NOA for NeuVax patent app in Japan 11:59 a.m. Oct. 14, 2014 - Seeking Alpha
FDA clears Akynzeo for chemo-induced nausea and vomiting 9:50 a.m. Oct. 10, 2014 - Seeking Alpha
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape 8:00 a.m. Oct. 9, 2014 - Zacks.com
Three Lessons From The Galena Scandal 10:02 a.m. Aug. 21, 2014 - Seeking Alpha
Galena Biopharma (GALE) Replaces CEO Mark Ahn 9:10 a.m. Aug. 21, 2014 - InvestorPlace.com
Galena CEO gets the boot 6:33 a.m. Aug. 21, 2014 - Seeking Alpha
Galena CEO Fired Following Stock-Promotions Scandal 6:16 a.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 6:22 a.m. Aug. 15, 2014 - TheStreet.com
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings Call Transcript 8:17 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 4:19 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
20 Cheap Stocks Under $10 Worth Zilch 4:40 a.m. Aug. 5, 2014 - InvestorPlace.com
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 4:22 p.m. Aug. 4, 2014 - Seeking Alpha
Galectin Pays Stock Promoters to Entice Retail Investors 11:34 a.m. July 28, 2014 - TheStreet.com
Galena Gives Sales Team Another Useless Product to Promote 8:41 a.m. July 22, 2014 - TheStreet.com
Galena secures U.S. rights to serotonin blocker 7:33 a.m. July 22, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 10:11 a.m. July 8, 2014 - Barrons.com
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 8:49 a.m. July 2, 2014 - TheStreet.com

Galena Biopharma to Present at the Stifel 2014 Healthcare Conference 7:06 a.m. Nov. 13, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients 7:06 a.m. Nov. 11, 2014 - GlobeNewswire
Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting 7:06 a.m. Nov. 7, 2014 - GlobeNewswire
Galena Biopharma to Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data at the Society for the Immunotherapy of Cancer (SITC) 29th Annual Meeting on Friday, November 7, 2014 7:06 a.m. Nov. 4, 2014 - GlobeNewswire
Heat Biologics Takes a New Approach to Immunotherapy 2:01 p.m. Nov. 3, 2014 - ACCESSWIRE
The most undervalued, yet comprehensive cancer immunotherapy in development? 8:04 a.m. Nov. 3, 2014 - ACCESSWIRE
Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 6:06 a.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan 6:05 a.m. Oct. 14, 2014 - GlobeNewswire
Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination 6:06 a.m. Oct. 8, 2014 - GlobeNewswire
Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update 3:15 p.m. Sept. 25, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial 6:05 a.m. Sept. 9, 2014 - GlobeNewswire
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 8:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 6:06 a.m. Sept. 3, 2014 - GlobeNewswire
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer 6:05 a.m. Aug. 21, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 6:06 a.m. July 29, 2014 - GlobeNewswire
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film 6:16 a.m. July 22, 2014 - GlobeNewswire
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film 6:06 a.m. July 22, 2014 - GlobeNewswire
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 4:30 a.m. July 4, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Electra Defense's $4.7M Contract Fuels USAF Innovation

Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...

Trimble Unveils Bold AI Tools in Construction Push

Trimble Connect's Bold Move in AI In the relentless world of construction, where risk is as common as a hard hat, Trimble's rolling out some heavy-duty AI capabilities. Today, at the annual Trimble Dimensions bash in Las Vegas, the bigwigs at Trimble (NASDAQ:TRMB) flashed their latest trick: Trimble Connect's AI arsenal. It's not just a software upgrade; it's practically...

Solstice Advances Foam Agent with Eco-Friendly Twist

A New Phase in Foam Blowing Agents You don’t come across a true leap in materials technology every day, and that’s exactly what's unfolding with Solstice Advanced Materials' latest venture. They’re not just talking the talk; they've hit a milestone in developing a next-gen foam blowing agent. This isn't just another tweak in a spreadsheet—it's a potential pivot in...

NSAP's First Board Aims to Revolutionize Autism Care

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Texas Author's Memoir Journeys Through Trauma and Growth

Finding Clarity Amid Chaos When life throws the unexpected, some folks crumble, but others, like Joyce L. Skala, sift through the rubble for clarity. Her debut memoir, "There's No Such Thing as Bad," weaves through personal chaos—embracing trauma and loss like a late-night poker game where the house always wins. Born from the charred memories of her family's home...

Outer Spaces Unveils OS1 at Major Energy Expo

Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...

Inner City Visions Celebrates Two Decades of Impact

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Foundayo Aims to Revolutionize Sleep Apnea Treatment

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...